CCP
ROIV icon

Corbin Capital Partners’s Roivant Sciences ROIV Stock Holding History

Corbin Capital Partners’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$552K Sell
46,641
-104,245
-69% -$1.23M 0.9% 9
2024
Q3 		$1.74M Sell
150,886
-20,000
-12% -$228K 2.2% 7
2024
Q2 		$1.81M Hold
170,886
– – 3.48% 10
2024
Q1 		$1.8M Buy
+170,886
New +$1.84M 3.05% 9

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Corbin Capital Partners's ROIV Position: Q4 2024 in Review

Corbin Capital Partners reduced its Roivant Sciences (ROIV) stake by 69% in Q4 2024, selling an estimated $1.23M and leaving 46,641 shares worth $552K. The position accounts for 0.9% of the portfolio, ranked #9.

Corbin Capital Partners first reported a position in ROIV in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.81M in Q2 2024. 319 funds tracked by Wall St. Rank hold ROIV as of Q4 2024.

  • Corbin Capital Partners held 46,641 shares of Roivant Sciences worth $552K as of Q4 2024.
  • Corbin Capital Partners sold 104,245 Roivant Sciences shares in Q4 2024, an estimated $1.23M.
  • Roivant Sciences made up 0.9% of Corbin Capital Partners's portfolio in Q4 2024, its #9 holding.
  • Corbin Capital Partners first reported a position in Roivant Sciences in Q1 2024 and has held it in 4 quarters since.
  • Corbin Capital Partners's Roivant Sciences position peaked at $1.81M in Q2 2024.
  • 319 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2024.

Based on Corbin Capital Partners's 13F filing for Q4 2024, filed 11 Feb 2025.